Caring Brands Stock Price, News & Analysis
Company Description
Caring Brands, Inc. (NASDAQ: CABR) is described as a wellness consumer products company that offers several over-the-counter (OTC) and cosmetic consumer products. According to company disclosures, its focus is on health and wellness needs that include hair loss, eczema, psoriasis, vitiligo, and protection from jellyfish stings.
The company is also characterized as a consumer wellness business that supports health and wellness through research and development. Its product pipeline addresses a range of conditions, including hair loss, eczema, burns, and sexual wellness. Revenue is stated to be generated primarily from the sale of OTC and consumer products, as well as licensing royalties.
Business focus and product pipeline
Caring Brands reports a growing portfolio of unique, patented, and clinically validated products for skin and hair growth. The company has indicated plans to launch multiple products and to in-license additional products to expand its wellness portfolio.
Disclosed product and pipeline examples include:
- Hair loss treatments, including Hair Enzyme Booster for the treatment of hair loss
- Photocil for the treatment of psoriasis and vitiligo
- CB-101 for the treatment of eczema
- NoStingz, a sunscreen that is described as preventing jellyfish stings
- Product candidates and concepts for burns and sexual wellness
The company states that revenues from Hair Enzyme Booster and Photocil are generated through direct sales in the United States and through licensees in India.
Approach to product development
Caring Brands describes a defined method of operation for its wellness and cosmetic products. The company states that for its products:
- The mechanism of action is established
- Efficacy is determined through controlled clinical trials
- Products are protected by issued and filed patents
- Products have acceptable commercial stability
This stated approach is intended to support the development and commercialization of OTC and cosmetic products that address specific dermatological and wellness conditions.
Licensing and commercialization model
The company reports that a majority of its revenue is generated from the sale of OTC and consumer products and from licensing royalties. It has disclosed that it works with licensees in markets such as India for certain products, while also engaging in direct sales in the United States.
Caring Brands also pursues in-licensing opportunities. For example, it has announced an exclusive worldwide license agreement with Itonis Inc. to manufacture, market, and distribute Emesyl, an OTC nausea relief product. Under that agreement, Caring Brands assumes responsibility for product manufacturing, marketing, sales strategy, and global distribution, while Itonis provides technical information, product formulation data, historical sales information, and intellectual property details.
Emesyl exclusive global license
Through the Emesyl agreement, Caring Brands states that it has obtained full rights to commercialize this nausea relief product and to oversee all manufacturing activities associated with it. The agreement includes a royalty structure based on future net sales and the potential for Caring Brands to earn equity in Itonis tied to revenue milestones.
The company has described this license as an important step in expanding its health and wellness portfolio and aligning with its long-term strategy for OTC products.
Capital markets and listing
Caring Brands has announced that its common shares are listed on the Nasdaq Capital Market under the symbol CABR. In connection with an underwritten U.S. public offering, the company disclosed that its shares commenced trading on the Nasdaq Capital Market under this ticker, and that its common stock ceased to be traded on the OTCQB at that time.
The company has also stated that it filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission in relation to this offering, and that the registration statement was declared effective.
Geographic and operational notes
Company press releases reference locations in Florida, including Fort Pierce and Jupiter, in connection with corporate announcements. Caring Brands also notes commercial activity in the United States and licensing relationships in India for certain products.
Management and strategic activities
According to company statements, management has a track record that includes strategic acquisitions, rapid product development, intellectual property development, and product licensing. The company positions these capabilities as part of its approach to building and expanding a portfolio of wellness and cosmetic products.
Summary
In summary, Caring Brands, Inc. is presented as a wellness consumer products company focused on OTC and cosmetic products that address dermatological and wellness conditions such as hair loss, eczema, psoriasis, vitiligo, burns, nausea, sexual wellness, and jellyfish stings. It combines direct product sales with licensing arrangements, emphasizes patented and clinically validated products, and participates in capital markets through its listing on the Nasdaq Capital Market under the symbol CABR.
Stock Performance
Caring Brands (CABR) stock last traded at $1.21, up 6.03% from the previous close. Over the past 12 months, the stock has lost 60.3%. At a market capitalization of $14.3M, CABR is classified as a micro-cap stock with approximately 12.3M shares outstanding.
Latest News
Caring Brands has 4 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 2 with negative movement. View all CABR news →
SEC Filings
Caring Brands has filed 5 recent SEC filings, including 2 Form 4, 2 Form 8-K, 1 Form 10-K. The most recent filing was submitted on April 10, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CABR SEC filings →
Financial Highlights
Caring Brands generated $4K in revenue over the trailing twelve months, retaining a 55.6% gross margin, operating income reached -$5.9M (-140807.2% operating margin), and net income was -$6.3M, reflecting a -148948.8% net profit margin. Diluted earnings per share stood at $-0.46. The company generated -$1.7M in operating cash flow. With a current ratio of 13.16, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Caring Brands (CABR) currently stands at 47.9 thousand shares, down 48.0% from the previous reporting period, representing 0.7% of the float. Over the past 12 months, short interest has increased by 451.9%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Caring Brands (CABR) currently stands at 1.0 days, down 23.1% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CABR Company Profile & Sector Positioning
Caring Brands (CABR) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Perfumes, Cosmetics & Other Toilet Preparations sector and is listed on the NASDAQ.